Moderate riskFDA DrugClass III

Somerset Therapeutics cisatracurium besylate injection recalled for subpotent drug strength

Somerset Therapeutics is recalling cisatracurium besylate injection (200mg/20mL vials, Lot #A250020, expiration 06/30/2026) because stability testing found the drug's strength fell below required standards. This means the medication may not work as intended during medical procedures.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have Lot #A250020 (expiration 06/30/2026), stop using it immediately
  2. Contact your pharmacy or healthcare facility to confirm whether you have affected vials
  3. Speak with your doctor or pharmacist about obtaining a replacement supply

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
28,660 20mL vials
Illnesses reported
None reported
Manufactured in
300 Franklin Square Dr, Somerset, NJ, United States
Classification
Class III
Recall number
D-0237-2026

In the FDA's words

Description
Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10. Subpotent product:out of specification assay results observed during long term stability testing. Lot #: A250020, Exp Date 06/30/2026 Distribution: Nationwide in the USA Affected quantity: 28,660 20mL vials
Hazard
Subpotent product:out of specification assay results observed during long term stability testing.

3 products in this recall

Somerset cisatracurium injection recalled for low potency

Somerset Therapeutics is recalling three cisatracurium besylate injection products because testing found the drug may be weaker than its label states. The recall covers 10 mg/5 mL, 200 mg/20 mL and 20 mg/10 mL vials, all made by Somerset Therapeutics in India and distributed nationwide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug